IP Verse

Pfizer Inc. V. Sun Pharmaceutical Industries Limited - 1:23-cv-00718

Explore the details of the Pfizer Inc. V. Sun Pharmaceutical Industries Limited case under case number 1:23-cv-00718 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-00718
Filing Date
Jun 30, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
PF Prism IMB B.V. -
C.P. Pharmaceuticals International C.V. -
Sun Pharmaceutical Industries, Inc. -
Pfizer Inc. -
PBG Puerto Rico LLC -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jun 30, 2023Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 07/03/2023)PACER Document
Jun 30, 2023COMPLAINT filed against Sun Pharmaceutical Industries Limited and Sun Pharmaceutical Industries, Inc. (Filing fee $ 402, receipt number ADEDC-4170442.) - filed by PBG Puerto Rico LLC, Pfizer Inc., PF Prism IMB B.V., C.P. Pharmaceuticals International C.V., and PF Prism C.V. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mkr) (Entered: 07/03/2023)PACER Document
Jun 30, 2023Summons Issued as to Sun Pharmaceutical Industries Limited on 6/30/2023; Sun Pharmaceutical Industries, Inc. on 6/30/2023. (Attachments: # 1 Summons Issued) (mkr) (Entered: 07/03/2023)PACER Document
Jun 30, 2023Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF Prism C.V., PF Prism IMB B.V., and Pfizer Inc. (mkr) (Entered: 07/03/2023)PACER Document
Jun 30, 2023Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E. (mkr) (Entered: 07/03/2023)PACER Document
Jun 30, 2023Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 22, 2023. Date of Expiration of Patent: December 8, 2025.Thirty Month Stay Deadline: 11/22/2025. (mkr) (Entered: 07/03/2023)PACER Document